Bronchial asthma

Слайд 2

Introduction

What is bronchial asthma?
Asthma is a long-term inflammatory disease of the airways of the lungs.[3] It is characterized by

Introduction What is bronchial asthma? Asthma is a long-term inflammatory disease of
variable and recurring symptoms, reversible airflow obstruction, and easily triggered bronchospasms

Слайд 3

Causes:

Asthma is caused by a combination of complex and incompletely understood environmental

Causes: Asthma is caused by a combination of complex and incompletely understood
and genetic interactions.
Environmental : allergens, pollens , air pollution & other chemicals.
Smoking
Chemical exposure(formaldehyde, pesticides)
Use of antibiotics in early life
Genetic

Слайд 4

Signs and symptoms

Wheezing, shortness of breathing
Chest tightness
Cough
Sputum may produce

Signs and symptoms Wheezing, shortness of breathing Chest tightness Cough Sputum may
by lungs but its often hard to bring up.
Associate condition (GERD,Rhino sinusitis)

Слайд 5

Pathophysiology

Asthma is the result of chronic inflammation of the conducting zone of the airways (most especially

Pathophysiology Asthma is the result of chronic inflammation of the conducting zone
the bronchi and bronchioles), which subsequently results in increased contractability of the surrounding smooth muscles.
This among other factors leads to bouts of narrowing of the airway and the classic symptoms of wheezing.
Typical changes in the airways include an increase in eosinophils and thickening of the lamina reticularis. 

Слайд 6

airways' smooth muscle may increase in size along with an increase in

airways' smooth muscle may increase in size along with an increase in
the numbers of mucous glands.
cell types involved include: T lymphocytes, macrophages, and neutrophils.
 may also be involvement of other components of the immune system including: cytokines, chemokines, histamine, and leukotrienesamong others.

Слайд 7

Diagnosis

Spirometry
Asthma exacerbatio
-Near-fatal high PaCO2, or requiring mechanical ventilation, or both

Diagnosis Spirometry Asthma exacerbatio -Near-fatal high PaCO2, or requiring mechanical ventilation, or
-Life-threatening:Oxygen saturation < 92%
-Acute severe:Peak flow 33–50%, Respiratory rate ≥ 25 breaths per minute, Heart rate ≥ 110 beats per minute & Unable to complete sentences in one breath

Слайд 8

Moderate :worsening symptomsPeak flow 50–80% best or predictedNo features of acute severe

Moderate :worsening symptomsPeak flow 50–80% best or predictedNo features of acute severe
asthma.
And also many induce asthma
-exercise induced
-occupational
-aspirin induced asthma
-alcohol induced asthma
-Non atopic asthma

Слайд 9

Prevention

Stop tobacco smoking
Decrease air pollution
Chemical irritants- perfume should be

Prevention Stop tobacco smoking Decrease air pollution Chemical irritants- perfume should be
stop using.
Identify and avoid asthma triggers. 
Get vaccinated for influenza and pneumonia.

Слайд 10

Management

Prevention of antigen-antibody reaction:Antigen avoidance, hyposensitization
Neutralization of IgE (reaginic antibody):Omalizumab
Prevention of

Management Prevention of antigen-antibody reaction:Antigen avoidance, hyposensitization Neutralization of IgE (reaginic antibody):Omalizumab
the release of mediators: Mast cell stabilizers
Suppression of inflammation and bronchial hyper-reactivity: Corticosteroids
Antagonism of released mediators: Leukotriene antagonist, Antihistamines
Blockade of constrictor neurotransmitter:Anticholinergics

Слайд 11

Directly acting bronchodilators: Methylxanthines
Bronchodilators:
1. β2-sympathomimetics (Salbutamol, Terbutaline etc)
2. Methylxanthines

Directly acting bronchodilators: Methylxanthines Bronchodilators: 1. β2-sympathomimetics (Salbutamol, Terbutaline etc) 2. Methylxanthines
(Theophylline, Aminophylline, )
3.Anticholinergics Tiotropium bromide)
Corticosteroids:
1. Systemic Corticosteroids (Hydrocortisone, Prednisolone)
2. Inhalational Corticosteroids (Beclomethasone, Budesonide, Fluticasone propionate, Flunisolide, Ciclesonide)